Skip to content Skip to footer
Rituxan Hycela: Benefits, Reviews, Info, Side Effects!
Rx Details
Rituxan Hycela
Rituximab, MabThera
Rituximab
Prescription
Biologic
Drugs
Prescription Only
reduced infusion time, treatment of certain types of non-Hodgkin’s lymphoma, treatment of chronic lymphocytic leukemia, subcutaneous administration, potential for fewer infusion-related reactions, convenience of administration
Cough, Diarrhea, Fatigue, Fever, Headache, Infections, Itching, Low Platelet Count, Low Red Blood Cell Count, Low White Blood Cell Count, Muscle Spasms, Nausea, Rash, Swelling At The Injection Site
Rituxan Hycela is a combination of rituximab and hyaluronidase used for the treatment of certain types of blood cancers. The dosage of Rituxan Hycela is not based on a standard average but is typically determined by the specific condition being treated, the patient’s body surface area, and other individual factors. For example, in the treatment of follicular lymphoma, the recommended dose is 1,400 mg of rituximab and 23,400 units of hyaluronidase administered subcutaneously. However, the exact dosing schedule and duration of treatment can vary based on the specific protocol being followed and the patient’s response to therapy. It’s important for patients to follow their healthcare provider’s instructions regarding dosage and administration. Always consult with a healthcare professional for personalized medical advice.
Non-hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis
Rituxan Hycela has a generally favorable safety profile.
Chemotherapy drugs, live vaccines
$1,000 – $10,000
$5,000

A Synopsis of

Rituxan Hycela

Rituxan Hycela is a medication that combines two powerful drugs, rituximab and hyaluronidase, to treat certain types of cancer and autoimmune diseases. Rituximab is a monoclonal antibody that targets specific proteins on the surface of cancer cells or immune cells, while hyaluronidase helps the medication to be absorbed more quickly and effectively into the body.

This combination therapy has been shown to be highly effective in treating conditions such as non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and granulomatosis with polyangiitis. By targeting and destroying cancer cells or regulating the immune system, Rituxan Hycela can help to slow the progression of these diseases and improve quality of life for patients.

As with any medication, there are potential side effects to be aware of when taking Rituxan Hycela. These can include infusion reactions, low blood cell counts, infections, and liver problems. It is important to discuss any concerns or symptoms with your healthcare provider to ensure the best possible outcome.

It is also important to follow your healthcare provider’s instructions carefully when taking Rituxan Hycela. This may include receiving the medication in a healthcare setting where you can be monitored for any potential side effects, as well as following a specific dosing schedule.

Overall, Rituxan Hycela is a valuable treatment option for patients with certain types of cancer and autoimmune diseases. By working with your healthcare provider and staying informed about your treatment plan, you can help to maximize the benefits of this medication and improve your overall health and well-being.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN